Dr. Agarwal's Health Care Limited (BOM:544350)

India · Delayed Price · Currency is INR

479.10

-2.40 (-0.50%)

At close: Jul 31, 2026

5.25% (1Y)

Market Cap	151.52B +5.3%
Revenue (ttm)	20.80B +21.6%
Net Income	1.33B +59.6%
EPS	4.18 +50.4%
Shares Out	n/a
PE Ratio	113.76
Forward PE	81.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,498
Open	479.25
Previous Close	481.50
Day's Range	473.80 - 487.10
52-Week Range	402.10 - 567.80
Beta	n/a
Analysts	Buy
Price Target	545.00 (+13.76%)
Earnings Date	Aug 4, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addit... [Read more]

Industry Health Services

Founded 2010

Employees 4,214

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544350

Full Company Profile

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 544350 stock is "Buy." The 12-month stock price target is ₹545.00, which is an increase of 13.76% from the latest price.

Price Target

₹545.00

(13.76% upside)

Analyst Consensus: Buy

Stock Forecasts